Vorapaxar in the secondary prevention of atherothrombotic events




Morrow DA, Braunwald E, Bonaca MP, Ameriso SF, Dalby AJ, Fish MP, Fox KA, Lipka LJ, Liu X, Nicolau JC, Ophuis AJ, Paolasso E, Scirica BM, Spinar J, Theroux P, Wiviott SD, Strony J, Murphy SA

2012

New England Journal of Medicine

366

12

366

144

1413

0028-4793




Last updated on 2024-26-11 at 12:15